Interpreting cell cycle effects of drugs: The case of melphalan

Monica Lupi, Paolo Cappella, Giada Matera, Claudia Natoli, Paolo Ubezio

Research output: Contribution to journalArticle

Abstract

Multiple effects usually occu-r in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and G2M checkpoints. We developed a simulation tool connecting the microscopic level of the cellular response in G1, S and G2M with the experimental data of growth inhibition and flow cytometry. We found that multiple - often not intuitive - combinations of cytostatic and cytotoxic effects can be in keeping with the observations. This multiplicity of interpretation can be strongly reduced by considering together data with different methods, ideally reaching a reconstruction of the underlying cell cycle perturbations. Here, we propose an experimental plan including a time course of DNA flow cytometry and absolute cell count measurements with several drug concentrations and a limited number of flow cytometric DNA-Bromode-oxyuridine and TUNEL analyses, coupled with computer simulation. We showed its use in the attempt to define the complete time course of the effects of melphalan on three cancer cell lines. After drug treatment, each subset of cells experienced blocks and lethality in all phases of the cell cycle, but the dynamics was different, the differences being strongly dose-dependent. Our approach allows a better appreciation of the complexity of the cell cycle phenomena associated with drug treatment. It is expected that such level of understanding of the time- and dose-dependence of the cytostatic and cytotoxic effects of a drug might support rational therapeutic design.

Original languageEnglish
Pages (from-to)443-457
Number of pages15
JournalCancer Chemotherapy and Pharmacology
Volume57
Issue number4
DOIs
Publication statusPublished - Apr 2006

Fingerprint

Melphalan
Cell Cycle
Cells
Pharmaceutical Preparations
Drug therapy
Cytostatic Agents
Flow cytometry
Flow Cytometry
DNA
In Situ Nick-End Labeling
Computer Simulation
Cell Count
Cell Line
Growth
Computer simulation
Neoplasms

Keywords

  • Anticancer drugs
  • Cell cycle
  • Flow cytometry
  • Mathematical models
  • Melphalan

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Interpreting cell cycle effects of drugs : The case of melphalan. / Lupi, Monica; Cappella, Paolo; Matera, Giada; Natoli, Claudia; Ubezio, Paolo.

In: Cancer Chemotherapy and Pharmacology, Vol. 57, No. 4, 04.2006, p. 443-457.

Research output: Contribution to journalArticle

Lupi, Monica ; Cappella, Paolo ; Matera, Giada ; Natoli, Claudia ; Ubezio, Paolo. / Interpreting cell cycle effects of drugs : The case of melphalan. In: Cancer Chemotherapy and Pharmacology. 2006 ; Vol. 57, No. 4. pp. 443-457.
@article{24d636508a144366953230ef83e76c93,
title = "Interpreting cell cycle effects of drugs: The case of melphalan",
abstract = "Multiple effects usually occu-r in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and G2M checkpoints. We developed a simulation tool connecting the microscopic level of the cellular response in G1, S and G2M with the experimental data of growth inhibition and flow cytometry. We found that multiple - often not intuitive - combinations of cytostatic and cytotoxic effects can be in keeping with the observations. This multiplicity of interpretation can be strongly reduced by considering together data with different methods, ideally reaching a reconstruction of the underlying cell cycle perturbations. Here, we propose an experimental plan including a time course of DNA flow cytometry and absolute cell count measurements with several drug concentrations and a limited number of flow cytometric DNA-Bromode-oxyuridine and TUNEL analyses, coupled with computer simulation. We showed its use in the attempt to define the complete time course of the effects of melphalan on three cancer cell lines. After drug treatment, each subset of cells experienced blocks and lethality in all phases of the cell cycle, but the dynamics was different, the differences being strongly dose-dependent. Our approach allows a better appreciation of the complexity of the cell cycle phenomena associated with drug treatment. It is expected that such level of understanding of the time- and dose-dependence of the cytostatic and cytotoxic effects of a drug might support rational therapeutic design.",
keywords = "Anticancer drugs, Cell cycle, Flow cytometry, Mathematical models, Melphalan",
author = "Monica Lupi and Paolo Cappella and Giada Matera and Claudia Natoli and Paolo Ubezio",
year = "2006",
month = "4",
doi = "10.1007/s00280-005-0044-1",
language = "English",
volume = "57",
pages = "443--457",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Interpreting cell cycle effects of drugs

T2 - The case of melphalan

AU - Lupi, Monica

AU - Cappella, Paolo

AU - Matera, Giada

AU - Natoli, Claudia

AU - Ubezio, Paolo

PY - 2006/4

Y1 - 2006/4

N2 - Multiple effects usually occu-r in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and G2M checkpoints. We developed a simulation tool connecting the microscopic level of the cellular response in G1, S and G2M with the experimental data of growth inhibition and flow cytometry. We found that multiple - often not intuitive - combinations of cytostatic and cytotoxic effects can be in keeping with the observations. This multiplicity of interpretation can be strongly reduced by considering together data with different methods, ideally reaching a reconstruction of the underlying cell cycle perturbations. Here, we propose an experimental plan including a time course of DNA flow cytometry and absolute cell count measurements with several drug concentrations and a limited number of flow cytometric DNA-Bromode-oxyuridine and TUNEL analyses, coupled with computer simulation. We showed its use in the attempt to define the complete time course of the effects of melphalan on three cancer cell lines. After drug treatment, each subset of cells experienced blocks and lethality in all phases of the cell cycle, but the dynamics was different, the differences being strongly dose-dependent. Our approach allows a better appreciation of the complexity of the cell cycle phenomena associated with drug treatment. It is expected that such level of understanding of the time- and dose-dependence of the cytostatic and cytotoxic effects of a drug might support rational therapeutic design.

AB - Multiple effects usually occu-r in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and G2M checkpoints. We developed a simulation tool connecting the microscopic level of the cellular response in G1, S and G2M with the experimental data of growth inhibition and flow cytometry. We found that multiple - often not intuitive - combinations of cytostatic and cytotoxic effects can be in keeping with the observations. This multiplicity of interpretation can be strongly reduced by considering together data with different methods, ideally reaching a reconstruction of the underlying cell cycle perturbations. Here, we propose an experimental plan including a time course of DNA flow cytometry and absolute cell count measurements with several drug concentrations and a limited number of flow cytometric DNA-Bromode-oxyuridine and TUNEL analyses, coupled with computer simulation. We showed its use in the attempt to define the complete time course of the effects of melphalan on three cancer cell lines. After drug treatment, each subset of cells experienced blocks and lethality in all phases of the cell cycle, but the dynamics was different, the differences being strongly dose-dependent. Our approach allows a better appreciation of the complexity of the cell cycle phenomena associated with drug treatment. It is expected that such level of understanding of the time- and dose-dependence of the cytostatic and cytotoxic effects of a drug might support rational therapeutic design.

KW - Anticancer drugs

KW - Cell cycle

KW - Flow cytometry

KW - Mathematical models

KW - Melphalan

UR - http://www.scopus.com/inward/record.url?scp=30644469760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30644469760&partnerID=8YFLogxK

U2 - 10.1007/s00280-005-0044-1

DO - 10.1007/s00280-005-0044-1

M3 - Article

C2 - 16195878

AN - SCOPUS:30644469760

VL - 57

SP - 443

EP - 457

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 4

ER -